Wayne G Shreffler, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peanut Hypersensitivity | 42 | 2024 | 163 | 9.360 |
Why?
|
Allergens | 57 | 2024 | 1320 | 5.300 |
Why?
|
Food Hypersensitivity | 32 | 2024 | 622 | 5.280 |
Why?
|
Desensitization, Immunologic | 28 | 2024 | 483 | 4.210 |
Why?
|
Immunoglobulin E | 41 | 2024 | 1463 | 2.910 |
Why?
|
Antigens, Plant | 14 | 2023 | 86 | 2.740 |
Why?
|
Basophils | 11 | 2022 | 389 | 2.670 |
Why?
|
Th2 Cells | 11 | 2021 | 1061 | 2.380 |
Why?
|
Milk Hypersensitivity | 13 | 2024 | 76 | 2.250 |
Why?
|
2S Albumins, Plant | 10 | 2023 | 28 | 2.200 |
Why?
|
Basophil Degranulation Test | 4 | 2019 | 16 | 1.940 |
Why?
|
Anaphylaxis | 8 | 2024 | 746 | 1.600 |
Why?
|
Eosinophilic Esophagitis | 7 | 2023 | 168 | 1.520 |
Why?
|
Plant Proteins | 9 | 2023 | 364 | 1.100 |
Why?
|
Hypersensitivity | 7 | 2020 | 1102 | 1.040 |
Why?
|
Immunoassay | 5 | 2017 | 752 | 1.020 |
Why?
|
Glycoproteins | 7 | 2015 | 2266 | 0.980 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 4 | 2022 | 805 | 0.980 |
Why?
|
Proctocolitis | 5 | 2023 | 25 | 0.940 |
Why?
|
Anti-Allergic Agents | 3 | 2024 | 141 | 0.930 |
Why?
|
Immune Tolerance | 10 | 2018 | 2259 | 0.830 |
Why?
|
Complementarity Determining Regions | 2 | 2021 | 149 | 0.800 |
Why?
|
Retinal Dehydrogenase | 1 | 2020 | 74 | 0.770 |
Why?
|
Cytokines | 8 | 2019 | 7323 | 0.760 |
Why?
|
Epitope Mapping | 6 | 2011 | 311 | 0.750 |
Why?
|
Adjuvants, Immunologic | 3 | 2012 | 1000 | 0.700 |
Why?
|
Hypersensitivity, Immediate | 5 | 2017 | 337 | 0.680 |
Why?
|
Transdermal Patch | 1 | 2019 | 51 | 0.670 |
Why?
|
Skin Tests | 17 | 2023 | 613 | 0.650 |
Why?
|
Immunologic Memory | 3 | 2021 | 1348 | 0.640 |
Why?
|
Immunity, Innate | 6 | 2021 | 2962 | 0.630 |
Why?
|
Administration, Oral | 18 | 2023 | 3914 | 0.630 |
Why?
|
Microarray Analysis | 4 | 2011 | 767 | 0.610 |
Why?
|
Epitopes | 10 | 2023 | 2571 | 0.600 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2018 | 2988 | 0.600 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 973 | 0.590 |
Why?
|
Diet Therapy | 1 | 2017 | 154 | 0.570 |
Why?
|
Enterocolitis | 3 | 2023 | 102 | 0.540 |
Why?
|
Immunoglobulin G | 10 | 2016 | 4561 | 0.530 |
Why?
|
Flow Cytometry | 4 | 2017 | 5974 | 0.520 |
Why?
|
Food | 6 | 2023 | 772 | 0.480 |
Why?
|
Lymphocyte Subsets | 1 | 2015 | 315 | 0.480 |
Why?
|
Immunization | 3 | 2019 | 1256 | 0.450 |
Why?
|
Child, Preschool | 41 | 2024 | 41005 | 0.420 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2540 | 0.420 |
Why?
|
Milk Proteins | 5 | 2024 | 169 | 0.410 |
Why?
|
Vitamin A | 1 | 2015 | 615 | 0.410 |
Why?
|
Dendritic Cells | 3 | 2020 | 2725 | 0.410 |
Why?
|
Child | 51 | 2024 | 77709 | 0.410 |
Why?
|
Feeding Methods | 1 | 2011 | 35 | 0.400 |
Why?
|
Infant Formula | 1 | 2013 | 199 | 0.400 |
Why?
|
Weaning | 1 | 2011 | 105 | 0.400 |
Why?
|
Amino Acid Sequence | 5 | 2021 | 13814 | 0.390 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2010 | 87 | 0.390 |
Why?
|
Drug Utilization | 2 | 2014 | 1183 | 0.390 |
Why?
|
Infant Food | 1 | 2011 | 141 | 0.390 |
Why?
|
Integrins | 1 | 2015 | 846 | 0.380 |
Why?
|
Humans | 116 | 2024 | 744366 | 0.350 |
Why?
|
Vaccines | 1 | 2018 | 823 | 0.350 |
Why?
|
Egg Hypersensitivity | 4 | 2012 | 44 | 0.340 |
Why?
|
Eczema | 3 | 2021 | 231 | 0.330 |
Why?
|
Cesarean Section | 2 | 2014 | 1365 | 0.330 |
Why?
|
Animal Technicians | 2 | 2018 | 7 | 0.320 |
Why?
|
Food Labeling | 2 | 2023 | 178 | 0.320 |
Why?
|
Dose-Response Relationship, Immunologic | 4 | 2018 | 370 | 0.320 |
Why?
|
Intestines | 2 | 2014 | 1924 | 0.320 |
Why?
|
Immunotherapy | 3 | 2024 | 4446 | 0.320 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10183 | 0.300 |
Why?
|
Infant | 29 | 2024 | 35134 | 0.300 |
Why?
|
Dietary Proteins | 3 | 2023 | 963 | 0.290 |
Why?
|
Complement Activation | 1 | 2009 | 453 | 0.290 |
Why?
|
Receptors, IgE | 4 | 2020 | 389 | 0.280 |
Why?
|
Cell Adhesion Molecules | 2 | 2018 | 1602 | 0.280 |
Why?
|
Intestinal Mucosa | 2 | 2016 | 3037 | 0.280 |
Why?
|
Nut Hypersensitivity | 2 | 2019 | 23 | 0.270 |
Why?
|
HLA-DQ Antigens | 1 | 2006 | 210 | 0.270 |
Why?
|
B-Lymphocytes | 2 | 2019 | 4666 | 0.270 |
Why?
|
Antigens, Differentiation | 1 | 2009 | 927 | 0.270 |
Why?
|
Complement System Proteins | 1 | 2009 | 795 | 0.260 |
Why?
|
Antibodies, Monoclonal | 2 | 2019 | 9274 | 0.250 |
Why?
|
Antibody Formation | 2 | 2022 | 1402 | 0.250 |
Why?
|
Vitamin D | 2 | 2015 | 3224 | 0.240 |
Why?
|
HLA-DR Antigens | 1 | 2006 | 645 | 0.240 |
Why?
|
Antibody Specificity | 5 | 2011 | 1095 | 0.240 |
Why?
|
Biological Assay | 1 | 2006 | 652 | 0.230 |
Why?
|
Cells, Cultured | 7 | 2020 | 19233 | 0.230 |
Why?
|
Lectins, C-Type | 1 | 2006 | 589 | 0.220 |
Why?
|
Lymphocyte Activation | 4 | 2020 | 5524 | 0.220 |
Why?
|
Administration, Cutaneous | 3 | 2020 | 711 | 0.220 |
Why?
|
Eosinophils | 3 | 2018 | 955 | 0.210 |
Why?
|
Enteritis | 1 | 2023 | 165 | 0.210 |
Why?
|
Adolescent | 29 | 2024 | 85779 | 0.210 |
Why?
|
Male | 51 | 2024 | 350115 | 0.210 |
Why?
|
Algorithms | 4 | 2017 | 13882 | 0.200 |
Why?
|
Gastritis | 1 | 2023 | 196 | 0.200 |
Why?
|
Biological Products | 2 | 2022 | 860 | 0.200 |
Why?
|
Food Analysis | 1 | 2022 | 104 | 0.200 |
Why?
|
Occupational Exposure | 3 | 2018 | 1793 | 0.200 |
Why?
|
Milk | 4 | 2013 | 450 | 0.200 |
Why?
|
Animals | 26 | 2024 | 168768 | 0.190 |
Why?
|
Protein Array Analysis | 5 | 2011 | 411 | 0.190 |
Why?
|
Anti-Asthmatic Agents | 2 | 2016 | 536 | 0.190 |
Why?
|
Leukocytes, Mononuclear | 2 | 2010 | 1837 | 0.190 |
Why?
|
Immunologic Tests | 1 | 2021 | 103 | 0.190 |
Why?
|
Aptamers, Nucleotide | 1 | 2022 | 166 | 0.180 |
Why?
|
Double-Blind Method | 8 | 2020 | 12025 | 0.180 |
Why?
|
Receptors, Peptide | 1 | 2021 | 272 | 0.180 |
Why?
|
Child Development | 1 | 2011 | 2223 | 0.180 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2020 | 181 | 0.170 |
Why?
|
Female | 46 | 2024 | 380193 | 0.170 |
Why?
|
Anti-Bacterial Agents | 2 | 2014 | 7182 | 0.170 |
Why?
|
Pyrophosphatases | 2 | 2012 | 137 | 0.170 |
Why?
|
Signal Transduction | 2 | 2012 | 23404 | 0.170 |
Why?
|
Th1-Th2 Balance | 1 | 2018 | 38 | 0.170 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2022 | 347 | 0.170 |
Why?
|
Eosinophilia | 1 | 2023 | 541 | 0.170 |
Why?
|
Serologic Tests | 1 | 2021 | 374 | 0.160 |
Why?
|
Phosphoric Diester Hydrolases | 2 | 2012 | 197 | 0.160 |
Why?
|
Population Groups | 1 | 2019 | 209 | 0.160 |
Why?
|
Seed Storage Proteins | 2 | 2010 | 12 | 0.160 |
Why?
|
Lymphokines | 1 | 2021 | 949 | 0.160 |
Why?
|
Endotoxins | 2 | 2017 | 527 | 0.160 |
Why?
|
Tretinoin | 1 | 2020 | 517 | 0.150 |
Why?
|
Egg White | 2 | 2008 | 18 | 0.150 |
Why?
|
Peptides | 2 | 2009 | 4410 | 0.150 |
Why?
|
Air Pollutants, Occupational | 2 | 2017 | 408 | 0.150 |
Why?
|
Single-Cell Analysis | 3 | 2022 | 2182 | 0.150 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 2865 | 0.140 |
Why?
|
Mast Cells | 3 | 2019 | 1544 | 0.140 |
Why?
|
Confidence Intervals | 2 | 2020 | 2971 | 0.140 |
Why?
|
Biotechnology | 1 | 2018 | 281 | 0.140 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2022 | 985 | 0.140 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2019 | 548 | 0.140 |
Why?
|
Cross Reactions | 1 | 2017 | 841 | 0.130 |
Why?
|
Chemokines, CC | 2 | 2013 | 291 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3921 | 0.130 |
Why?
|
Toll-Like Receptor 4 | 1 | 2018 | 565 | 0.130 |
Why?
|
Gastrointestinal Tract | 1 | 2021 | 814 | 0.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2022 | 3595 | 0.120 |
Why?
|
Immunomodulation | 1 | 2018 | 541 | 0.120 |
Why?
|
Budesonide | 1 | 2015 | 154 | 0.120 |
Why?
|
Sensitivity and Specificity | 5 | 2022 | 14723 | 0.120 |
Why?
|
Asthma | 3 | 2023 | 6010 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2022 | 4386 | 0.120 |
Why?
|
8,11,14-Eicosatrienoic Acid | 1 | 2013 | 62 | 0.120 |
Why?
|
Receptors, CCR8 | 1 | 2013 | 27 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 1222 | 0.120 |
Why?
|
Membrane Proteins | 5 | 2022 | 7882 | 0.120 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2013 | 102 | 0.110 |
Why?
|
Epinephrine | 2 | 2022 | 792 | 0.110 |
Why?
|
Endoscopy, Digestive System | 1 | 2015 | 345 | 0.110 |
Why?
|
Probiotics | 1 | 2016 | 351 | 0.110 |
Why?
|
Respiratory Sounds | 1 | 2017 | 696 | 0.110 |
Why?
|
Histamine Release | 1 | 2012 | 142 | 0.100 |
Why?
|
Eating | 1 | 2019 | 1536 | 0.100 |
Why?
|
Soy Foods | 1 | 2012 | 48 | 0.100 |
Why?
|
Treatment Outcome | 6 | 2020 | 63107 | 0.100 |
Why?
|
Clone Cells | 1 | 2015 | 1692 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2020 | 4208 | 0.100 |
Why?
|
Juglans | 1 | 2011 | 43 | 0.100 |
Why?
|
Neutrophil Infiltration | 1 | 2013 | 391 | 0.100 |
Why?
|
Monocytes | 1 | 2020 | 2596 | 0.100 |
Why?
|
Lens Plant | 1 | 2010 | 3 | 0.100 |
Why?
|
Adult | 22 | 2024 | 214052 | 0.100 |
Why?
|
Drug Synergism | 1 | 2015 | 1794 | 0.100 |
Why?
|
Plants | 1 | 2012 | 316 | 0.090 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 12073 | 0.090 |
Why?
|
Adrenergic Agonists | 1 | 2009 | 58 | 0.090 |
Why?
|
Treatment Failure | 1 | 2015 | 2618 | 0.090 |
Why?
|
Antibody Affinity | 1 | 2010 | 254 | 0.090 |
Why?
|
Lactoglobulins | 1 | 2008 | 22 | 0.080 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2023 | 954 | 0.080 |
Why?
|
Cell Degranulation | 2 | 2020 | 287 | 0.080 |
Why?
|
Meat | 1 | 2012 | 592 | 0.080 |
Why?
|
Up-Regulation | 1 | 2018 | 4222 | 0.080 |
Why?
|
Cell Differentiation | 2 | 2020 | 11486 | 0.080 |
Why?
|
Receptors, IgG | 1 | 2012 | 582 | 0.080 |
Why?
|
Caseins | 1 | 2008 | 104 | 0.080 |
Why?
|
Recombinant Proteins | 2 | 2011 | 6621 | 0.080 |
Why?
|
Interleukin-3 | 1 | 2009 | 444 | 0.080 |
Why?
|
Risk | 2 | 2017 | 9688 | 0.080 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2009 | 349 | 0.080 |
Why?
|
Dermatitis, Atopic | 2 | 2011 | 654 | 0.080 |
Why?
|
Cattle | 3 | 2024 | 3922 | 0.080 |
Why?
|
Nutrition Policy | 1 | 2011 | 488 | 0.070 |
Why?
|
Phytohemagglutinins | 1 | 2006 | 170 | 0.070 |
Why?
|
Folic Acid | 1 | 2013 | 1300 | 0.070 |
Why?
|
Lymphocyte Depletion | 1 | 2009 | 608 | 0.070 |
Why?
|
Urticaria | 1 | 2008 | 150 | 0.070 |
Why?
|
Age Factors | 2 | 2021 | 18373 | 0.070 |
Why?
|
Mitogens | 1 | 2006 | 232 | 0.070 |
Why?
|
Gene Expression | 3 | 2015 | 7798 | 0.070 |
Why?
|
Cell Proliferation | 2 | 2015 | 10483 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8642 | 0.070 |
Why?
|
Pseudomonas aeruginosa | 1 | 2013 | 1219 | 0.070 |
Why?
|
Young Adult | 11 | 2024 | 56429 | 0.070 |
Why?
|
Urban Population | 2 | 2017 | 2022 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4479 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2015 | 2108 | 0.070 |
Why?
|
Computational Biology | 1 | 2018 | 3519 | 0.070 |
Why?
|
Antigen-Antibody Reactions | 1 | 2005 | 363 | 0.070 |
Why?
|
Platelet Membrane Glycoproteins | 1 | 2006 | 293 | 0.060 |
Why?
|
Blood Specimen Collection | 1 | 2006 | 246 | 0.060 |
Why?
|
Mice | 8 | 2020 | 81201 | 0.060 |
Why?
|
Vitamins | 1 | 2013 | 1623 | 0.060 |
Why?
|
Syndrome | 2 | 2023 | 3252 | 0.060 |
Why?
|
Intestinal Absorption | 1 | 2006 | 420 | 0.060 |
Why?
|
Environmental Exposure | 2 | 2017 | 4232 | 0.060 |
Why?
|
Lipopolysaccharides | 2 | 2017 | 2216 | 0.060 |
Why?
|
Thyroid Diseases | 1 | 2008 | 379 | 0.060 |
Why?
|
Prognosis | 2 | 2019 | 29060 | 0.060 |
Why?
|
Ligands | 2 | 2013 | 3282 | 0.060 |
Why?
|
Case-Control Studies | 4 | 2022 | 21748 | 0.060 |
Why?
|
Reference Standards | 1 | 2006 | 1025 | 0.050 |
Why?
|
Environment | 1 | 2009 | 1123 | 0.050 |
Why?
|
Coculture Techniques | 1 | 2006 | 1341 | 0.050 |
Why?
|
Immunologic Factors | 2 | 2022 | 1580 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2008 | 1284 | 0.050 |
Why?
|
Emollients | 1 | 2021 | 34 | 0.050 |
Why?
|
Molecular Sequence Data | 4 | 2010 | 18111 | 0.050 |
Why?
|
Powders | 1 | 2021 | 80 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2024 | 3177 | 0.050 |
Why?
|
Cryopreservation | 1 | 2006 | 670 | 0.050 |
Why?
|
Risk Factors | 7 | 2022 | 72296 | 0.050 |
Why?
|
United States | 5 | 2023 | 69872 | 0.050 |
Why?
|
Vaccination | 2 | 2024 | 3279 | 0.050 |
Why?
|
Antigens | 1 | 2006 | 1466 | 0.050 |
Why?
|
Prevalence | 1 | 2017 | 15221 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2024 | 13035 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7282 | 0.050 |
Why?
|
Nuts | 1 | 2022 | 257 | 0.050 |
Why?
|
Fetal Blood | 1 | 2006 | 1318 | 0.050 |
Why?
|
No-Observed-Adverse-Effect Level | 1 | 2019 | 25 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2008 | 1837 | 0.040 |
Why?
|
Neuraminidase | 1 | 2020 | 210 | 0.040 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2019 | 87 | 0.040 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2019 | 123 | 0.040 |
Why?
|
Prospective Studies | 6 | 2023 | 53290 | 0.040 |
Why?
|
Cell Line | 4 | 2019 | 16000 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2024 | 598 | 0.040 |
Why?
|
Quality of Life | 2 | 2017 | 12802 | 0.040 |
Why?
|
ROC Curve | 2 | 2021 | 3528 | 0.040 |
Why?
|
Health Promotion | 1 | 2011 | 2205 | 0.040 |
Why?
|
Regression Analysis | 2 | 2020 | 6459 | 0.040 |
Why?
|
Occult Blood | 1 | 2020 | 176 | 0.040 |
Why?
|
Epithelial Cells | 2 | 2013 | 3690 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 541 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2022 | 995 | 0.040 |
Why?
|
Cohort Studies | 4 | 2015 | 40559 | 0.040 |
Why?
|
Hot Temperature | 3 | 2010 | 1356 | 0.040 |
Why?
|
Antigens, CD | 2 | 2006 | 4026 | 0.040 |
Why?
|
Infant, Newborn | 4 | 2023 | 25628 | 0.040 |
Why?
|
Palatine Tonsil | 1 | 2019 | 193 | 0.040 |
Why?
|
Hyperplasia | 1 | 2021 | 1185 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2005 | 2715 | 0.040 |
Why?
|
Middle Aged | 10 | 2024 | 213390 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39052 | 0.040 |
Why?
|
Animals, Laboratory | 1 | 2017 | 51 | 0.040 |
Why?
|
Models, Immunological | 1 | 2020 | 527 | 0.040 |
Why?
|
Respiratory System | 1 | 2021 | 557 | 0.040 |
Why?
|
Galectin 3 | 1 | 2019 | 227 | 0.040 |
Why?
|
Plant Extracts | 1 | 2021 | 471 | 0.040 |
Why?
|
Diet | 1 | 2015 | 7937 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 892 | 0.040 |
Why?
|
Medical History Taking | 1 | 2021 | 784 | 0.040 |
Why?
|
Glycosylation | 1 | 2020 | 1128 | 0.040 |
Why?
|
Interleukin-4 | 2 | 2010 | 1147 | 0.040 |
Why?
|
Conjunctivitis, Allergic | 1 | 2017 | 130 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2008 | 2134 | 0.030 |
Why?
|
Protein Binding | 2 | 2022 | 9384 | 0.030 |
Why?
|
Th1 Cells | 1 | 2021 | 1057 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2017 | 274 | 0.030 |
Why?
|
Placebo Effect | 1 | 2019 | 502 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2012 | 9955 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15535 | 0.030 |
Why?
|
Cities | 1 | 2017 | 513 | 0.030 |
Why?
|
Th17 Cells | 1 | 2021 | 766 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2012 | 0.030 |
Why?
|
Dust | 1 | 2017 | 482 | 0.030 |
Why?
|
Maine | 1 | 2013 | 139 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 3338 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12356 | 0.030 |
Why?
|
Research Design | 1 | 2009 | 5984 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2023 | 1978 | 0.030 |
Why?
|
Apoptosis | 1 | 2009 | 9724 | 0.030 |
Why?
|
Leukotriene B4 | 1 | 2013 | 294 | 0.030 |
Why?
|
Odds Ratio | 2 | 2017 | 9849 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2020 | 77460 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1584 | 0.030 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2013 | 379 | 0.030 |
Why?
|
DNA | 1 | 2006 | 7294 | 0.030 |
Why?
|
Housing | 1 | 2017 | 664 | 0.030 |
Why?
|
HIV Infections | 1 | 2018 | 16715 | 0.030 |
Why?
|
Administration, Sublingual | 1 | 2011 | 56 | 0.020 |
Why?
|
Eggs | 1 | 2012 | 184 | 0.020 |
Why?
|
Models, Biological | 2 | 2018 | 9584 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2013 | 675 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2013 | 690 | 0.020 |
Why?
|
Peroxidase | 1 | 2013 | 611 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 607 | 0.020 |
Why?
|
Respiratory Mucosa | 1 | 2013 | 427 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1170 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2278 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18034 | 0.020 |
Why?
|
Laboratories | 1 | 2013 | 463 | 0.020 |
Why?
|
Interleukin-5 | 1 | 2010 | 273 | 0.020 |
Why?
|
Forecasting | 1 | 2019 | 2951 | 0.020 |
Why?
|
Weight Gain | 1 | 2020 | 2293 | 0.020 |
Why?
|
Ovomucin | 1 | 2008 | 7 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5882 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6539 | 0.020 |
Why?
|
Nanoparticles | 1 | 2019 | 1905 | 0.020 |
Why?
|
Pruritus | 1 | 2010 | 361 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9735 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9312 | 0.020 |
Why?
|
Ovalbumin | 1 | 2008 | 719 | 0.020 |
Why?
|
Egg Proteins, Dietary | 1 | 2006 | 4 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10400 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13991 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2022 | 9445 | 0.020 |
Why?
|
Phylogeny | 1 | 2013 | 2804 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5218 | 0.020 |
Why?
|
Age of Onset | 1 | 2012 | 3270 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 19905 | 0.020 |
Why?
|
Transfection | 1 | 2013 | 5895 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 17446 | 0.020 |
Why?
|
Disease Progression | 1 | 2021 | 13286 | 0.010 |
Why?
|
Pregnancy | 2 | 2020 | 29144 | 0.010 |
Why?
|
Morbidity | 1 | 2009 | 1768 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3309 | 0.010 |
Why?
|
Aged | 3 | 2020 | 163288 | 0.010 |
Why?
|
Phenotype | 2 | 2011 | 16367 | 0.010 |
Why?
|
Protein Conformation | 1 | 2010 | 4010 | 0.010 |
Why?
|
Down-Regulation | 1 | 2009 | 3001 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21833 | 0.010 |
Why?
|
Feces | 1 | 2006 | 1401 | 0.010 |
Why?
|
Calcium | 1 | 2013 | 5755 | 0.010 |
Why?
|
Models, Molecular | 1 | 2010 | 5451 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4751 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10943 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23336 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10637 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 20952 | 0.010 |
Why?
|